Anna Senczuk
Senior Director & Head of Novel Modalities, Discovery Research CSL Seqirus
Anna Senczuk is Senior Director at CSL, bringing deep expertise in nucleic acids and bioprocess development from leadership roles across Resilience, GreenLight Biosciences, Shire, Pfizer, Takeda & Amgen. With a strong background in purification, protein chemistry, and advanced process development, she has led teams advancing RNA‑based modalities and innovative manufacturing strategies. Anna holds an M.Sc. and B.Sc. in Biochemistry from the University of Calgary and has over two decades of experience in biopharmaceutical R&D.
